SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-291672
Filing Date
2020-11-12
Accepted
2020-11-12 16:13:59
Documents
3
Period of Report
2020-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d95848d8k.htm 8-K 18323
2 EX-99.1 d95848dex991.htm EX-99.1 46988
3 GRAPHIC g95848g1112071221571.jpg GRAPHIC 2661
  Complete submission text file 0001193125-20-291672.txt   70286
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 201306834
SIC: 2836 Biological Products, (No Diagnostic Substances)